DMAAU — Drugs Made In America Acquisition Corp.
—
Nasdaq ·
Financials ·
Diversified Financial Services ·
CIK 2028614 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -143,301 | 1,970,459 | 242,035,303 | 14,887 | 7,392,169 |
| Dec 2025 | 0 | — | -2,089,466 | 212,958 | 239,918,847 | 6,137 | 7,276,172 |
| Sep 2025 | 0 | — | -263,703 | 2,184,563 | 237,632,428 | 717 | 7,356,611 |
| Jun 2025 | 0 | — | -131,919 | 2,288,579 | 235,205,692 | 822 | 7,201,441 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-539,187
Investing CF
$-231,150,000
Financing CF
$231,693,973
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
—
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-7,265,053
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-2,816,013
Pretax Income TTM
$5,940,643
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -2,816,013 | 5,940,643 | 239,918,847 | 7,276,172 | — | -539,187 |
| Dec 2024 | — | — | — | 550,824 | 795,669 | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HASI | HA Sustainable Infrastructure Capital, Inc. | $5.27B | $41.21 | — |
| DMII | Drugs Made In America Acquisition II Corp. | $641.46M | $10.07 | — |
| INV | Innventure, Inc. | $536.21M | $6.38 | — |
| BCSS | Bain Capital GSS Investment Corp. | $478.38M | $10.20 | — |
| EVAC | EQV Ventures Acquisition Corp. II | $477.46M | $10.17 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.